Informazione: Questa è una versione obsoleta del modello di dati. È possibile accedere alla versione corrente tramite Versioni a sinistra.
Informazione:
Errore:
ID
34332
Descrizione
Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC); ODM derived from: https://clinicaltrials.gov/show/NCT01392131
collegamento
https://clinicaltrials.gov/show/NCT01392131
Keywords
versioni (2)
- 16/01/19 16/01/19 -
- 14/05/19 14/05/19 -
Titolare del copyright
see on clinicaltrials.gov
Caricato su
16 gennaio 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Hepatocellular Carcinoma NCT01392131
Eligibility Hepatocellular Carcinoma NCT01392131
- StudyEvent: Eligibility
Similar models
Eligibility Hepatocellular Carcinoma NCT01392131
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
ID.1
Item
patients with hcc irrespective of etiology, age, gender and status of underlying liver disease.
boolean
ID.2
Item
patients with hcc who are not suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.3
Item
patients with hcc who have evidence of tumor metastasis
boolean
ID.4
Item
patients with hcc who are voluntarily unwilling to take established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.5
Item
patients with hcc in whom all possible treatment options have been exhausted.
boolean
ID.6
Item
patients with hcc who are suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.7
Item
patients with hcc who have no evidence of tumor metastasis
boolean
ID.8
Item
patients with hcc who are willing to take established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.9
Item
patients with hcc who are voluntarily unwilling to be included in the trial
boolean